Clancy Paul J
SEC-identified person · CIK 1409601 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Sionna Therapeutics, Inc. SION | Director | filed 2025 - 2026 |
| Incyte Corp INCY | Director | filed 2015 - 2026 |
| Exact Sciences Corp EXAS | Director | filed 2021 - 2026 |
| Xilio Therapeutics, Inc. XLO | Director | filed 2021 - 2025 |
| Agios Pharmaceuticals, INC. AGIO | Director | filed 2013 - 2022 |
| Alexion Pharmaceuticals, INC. alxn | EVP, Chief Financial Officer | filed 2017 - 2019 |
| Biogen INC. BIIB | Executive VP and CFO | filed 2007 - 2017 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.